issued
on 03 Dec 2024
Last Applicant/ Owned by
1400 Bridge Parkway, Suite 201
Redwood City
CA
94065
Serial Number
98405995 filed on 14th Feb 2024
Registration Number
N/A
Correspondent Address
Ted D. Karr
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Medical services for the prevention of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the localization of cancer Read More
Medical services for the prevention of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the localization of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for the localization of cancer; Medical services for the therapy of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for treating cancer; Medical services for the prevention of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the therapy of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for the treatment of cancer
N/A
N/A
Products for the prevention of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the localization of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for localization of cancer; Products for the therapy of cancer in humans, namely, pharmaceutical products to express a treatment agent for treating cancer; Products for the prevention of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the therapy of cancer in animals, namely, pharmaceutical products to express a treatment agent for treating cancer
N/A
N/A
No 98405995
No Service Mark
No 413.T003
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
03rd Dec 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
22nd Oct 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
22nd Oct 2024 | PUBLISHED FOR OPPOSITION |
02th Oct 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
16th Sep 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
06th Sep 2024 | ASSIGNED TO EXAMINER |
17th Jun 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
14th Feb 2024 | NEW APPLICATION ENTERED |